|
Volumn 24, Issue 3, 2001, Pages 147-151
|
The effect of prolactin and bromocriptine on human peripheral immune status
|
Author keywords
Bromocriptine; Immunomodulation; Prolactine
|
Indexed keywords
BROMOCRIPTINE;
CD16 ANTIGEN;
CD3 ANTIGEN;
CD8 ANTIGEN;
HLA DR ANTIGEN;
INTERLEUKIN 2 RECEPTOR;
PROLACTIN;
ARTICLE;
B LYMPHOCYTE ACTIVATION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORRELATION FUNCTION;
CYTOTOXICITY;
DRUG INHIBITION;
ENDOCRINE SURGERY;
FEMALE;
FLOW CYTOMETRY;
HUMAN;
HUMAN CELL;
HYPERPROLACTINEMIA;
IMMUNE STATUS;
MALE;
NATURAL KILLER CELL;
PROLACTIN BLOOD LEVEL;
T LYMPHOCYTE SUBPOPULATION;
ADENOMA;
ADULT;
ANTIGENS, CD3;
ANTIGENS, CD56;
BROMOCRIPTINE;
CD4-CD8 RATIO;
FEMALE;
FLOW CYTOMETRY;
HLA-DR ANTIGENS;
HUMANS;
HYPERPROLACTINEMIA;
KILLER CELLS, NATURAL;
LYMPHOCYTE SUBSETS;
LYMPHOCYTES;
MALE;
PITUITARY NEOPLASMS;
PROLACTIN;
RECEPTORS, IGG;
RECEPTORS, INTERLEUKIN-2;
|
EID: 0035068415
PISSN: 03914097
EISSN: None
Source Type: Journal
DOI: 10.1007/BF03343834 Document Type: Article |
Times cited : (9)
|
References (15)
|